This P30 Ophthalmology Core Facility renewal application is submitted to provide support for NEI-funded Oregon Health and Science University (OHSU) vision researchers in four Resource cores: Bio-Imaging & Confocal Microscopy (Bio-Imaging); Gene Expression & Manipulation (Gene Manipulation); Molecular Genetics & Biostatistics (Genetics/Biostats); and Proteomics & Mass Spectrometry (Proteomics). These shared resources will provide equipment and personnel that would otherwise not be available to individual researchers working in a diverse array of diseases affecting nearly all parts of the eye, including the anterior segment, trabecular meshwork, lens, retina, and optic nerve. Associated diseases include glaucoma, inherited retinal degenerations, macular degeneration, cataract, uveitis and the genetics of glaucoma and macular degeneration. Bio-Imaging will support immunofluorescence microscopy for identification and localization of proteins within tissues, as well as provide support for a new module using Spectral Domain OCT for in vivo imaging of rodent eyes. Gene manipulation will provide technical support and advice for a range of methods to identify changes in levels of gene expression and their products (proteins) that result either from disease states or their treatment, and for methods by which these responses can be manipulated, such as RNAi silencing, gene overexpression or gene variant/mutant expression via transfection or viral gene transfer agents. Methods for studying transcriptional regulation will also be available. Genetics/Biostats will provide DNA isolation services from patient samples to NEI-funded investigators, and will provide a wide range of biostatistical support, including advice on study design, data analysis, and expert assistance with sophisticated methods such as high dimensional data, advanced clustering analysis and transcription factor prediction from microarray data. The Proteomics core will provide access to advanced techniques for probing protein structure with higher sensitivity, throughput and accuracy. All 4 cores are highly complementary and, in combination with a departmental vision research seminar series, will foster a positive atmosphere of collaborative vision research.

Public Health Relevance

This Ophthalmology Core Facility grant will provide funding for support of four resource cores that will provide shared access for a large group of vision scientists to resources that they would not be able to supply individually. These cores consist of (1) sophisticated imaging of tissue samples and live-imaging to provide physiologic comparisons; (2) a group of methods to detect gene expression within tissues and their manipulation to determine disease mechanisms; (3) methods to aid gene discovery in patient and model samples and sophisticated biostatistical expertise to analyze complex gene expression patterns in both; and (4) methods of detecting complex protein composition in normal and diseased tissues.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Center Core Grants (P30)
Project #
5P30EY010572-24
Application #
9552816
Study Section
Special Emphasis Panel (ZEY1)
Program Officer
Liberman, Ellen S
Project Start
1997-05-01
Project End
2020-08-31
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
24
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Loh, Allison R; Edmunds, Beth; Peter Campbell, J et al. (2018) Ophthalmic imaging in children: current practice patterns and perceived barriers. J AAPOS 22:223-225.e3
Hagag, Ahmed M; Pechauer, Alex D; Liu, Liang et al. (2018) OCT Angiography Changes in the 3 Parafoveal Retinal Plexuses in Response to Hyperoxia. Ophthalmol Retina 2:329-336
Lu, Yansha; Simonett, Joseph M; Wang, Jie et al. (2018) Evaluation of Automatically Quantified Foveal Avascular Zone Metrics for Diagnosis of Diabetic Retinopathy Using Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci 59:2212-2221
Kim, Sang Jin; Port, Alexander D; Swan, Ryan et al. (2018) Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol 63:618-637
Adamus, Grazyna (2018) Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies? Front Immunol 9:765
Watson, Spencer S; Dane, Mark; Chin, Koei et al. (2018) Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes. Cell Syst 6:329-342.e6
Windsor, Matthew A; Sun, Sissi J J; Frick, Kevin D et al. (2018) Estimating Public and Patient Savings From Basic Research-A Study of Optical Coherence Tomography in Managing Antiangiogenic Therapy. Am J Ophthalmol 185:115-122
Shahidi, Mahnaz; Felder, Anthony E; Tan, Ou et al. (2018) Retinal Oxygen Delivery and Metabolism in Healthy and Sickle Cell Retinopathy Subjects. Invest Ophthalmol Vis Sci 59:1905-1909
Hirji, Nashila; Bradley, Patrick D; Li, Shuning et al. (2018) Jalili Syndrome: Cross-sectional and Longitudinal Features of Seven Patients With Cone-Rod Dystrophy and Amelogenesis Imperfecta. Am J Ophthalmol 188:123-130
McGill, Trevor J; Stoddard, Jonathan; Renner, Lauren M et al. (2018) Allogeneic iPSC-Derived RPE Cell Graft Failure Following Transplantation Into the Subretinal Space in Nonhuman Primates. Invest Ophthalmol Vis Sci 59:1374-1383

Showing the most recent 10 out of 429 publications